Coronavirus Update: Moderna And Pfizer Respond To Vaccine Trial Transparency Demands
Plus: Amgen Helps Lilly With Antibody Manufacturing
Executive Summary
Moderna led by releasing the trial protocol for its COVID-19 vaccine study, followed by Pfizer, as industry faces demands for transparency.
You may also be interested in...
‘Reckless’ State Campaigns Seek To Undermine Western COVID-19 Vaccines
China, Iran and especially Russia have launched campaigns aimed at undermining confidence in Western vaccines, especially Pfizer’s, according to two reports.
‘Reckless’ State Campaigns Seek To Undermine Western COVID-19 Vaccines
China, Iran and especially Russia have launched campaigns aimed at undermining confidence in Western vaccines, especially Pfizer’s, according to two reports.
Lilly Signs US Bamlanivimab Contract, Raising Unanswered Allocation Considerations
The price of the antibody monotherapy for COVID-19 will be $1,250 per vial for wealthy countries. CEO David Ricks outlined the company's guidelines for pricing and distributing a limited supply.